Navigation Links
Chiltern Opens a New Office in Russia
Date:4/13/2008

LONDON, April 14 /PRNewswire/ -- Chiltern, a leading global research organization, announced that it has opened a new office in St. Petersburg, Russia following the recent appointment of Dr. Alexey V. Kornilov as General Manager of its Russian operations.

This office is expected to grow rapidly under the leadership of Alexey V. Kornilov, MD and will be primarily focused on supporting our Global Clinical Development brand. Dr. Kornilov brings over 10 years of clinical experience to Chiltern and is a member of the St. Petersburg Society of Anesthesiology.

Over the last few years, Chiltern has conducted many trials in Russia to fulfill sponsors' demands in the region and to take advantage of highly qualified investigator sites generating high quality data.

"The opening of our St. Petersburg office is a logical next step in Chiltern's continued growth in Central & Eastern Europe," commented Armand Czaplinski MD, MBA, Chiltern General Manager, CEE. "Today, with an ever higher number of competing trials, the pharmaceutical industry increasingly recognizes the potential of CEE countries to meet enrollment goals. The availability of trained staff and the quality of the data produced, has resulted in an increased number of FDA and EMEA approved clinical trials."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1,200 people with 20 offices across the United States, Europe and in India. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

For More Information Contact:

Catherine Lemercier Richard Baptista

Chiltern International, Inc. Chilte
'/>"/>

SOURCE Chiltern
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
2. Chiltern Wins Top Prize
3. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
4. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
5. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
6. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
7. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
8. Marco Romano, MD Joins Chiltern as Medical Director, Europe
9. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
10. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
11. AVMA Opens Online Resource to General Public

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...otentially adding to preemie delivery rate, expert...s) -- Recent reports show that the rate of preterm...s. Now, a new study suggests one reason why: Many...term birth in the first place. , About one-quar...d a baby born at 34 to 36 weeks of gestation to be...
(Date:11/20/2009)...n with seasonal flu , , FRIDAY, Nov. 20...rting that children with asthma are more likely to...u. , "Asthma has been identified as a significa...fluenza, present in 21 percent to 30 percent in th...w researchers from the Hospital for Sick Children ...
(Date:11/20/2009)...warns against the new breast cancer recommendation...Force. These guidelines may be cost-effective, but... wrong to be safe than sorry? , ...ce recommendations, published in the current issue... firestorm in the medical community. Major medical...
(Date:11/20/2009)...wswire/ -- Missouri state employees in the Southwe...e the option to choose Mercy Health Plans thanks t...nsolidated Health Care Plan (MCHCP) and Mercy Heal...ssouri regions include the following counties: Bar...s, Greene, Hickory, Howell, Jasper, Laclede, Lawre...
(Date:11/20/2009)...0 California minority advocacy gro...he Wall/Las Memorias, Latina Breast Cancer Agency,... Real Medicine Foundation today sent a letter to B... reconsider harmful and discriminatory coverage po...ly calls for an end to the practice of step therap...
Breaking Medicine News(10 mins):Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 4
...earchers in the US felt that artistic skill is oft...nown how the brain influences artistic creativity....oke, dementia, or trauma// - would destroy your ab...visual art, fared when they suffered some kind of ...
...ording to pshycologists, believing that one can c...ur heart and circulation.// Exposure to a stressfu...use it increases blood pressure and resistance to ...moderated by many psychological factors, such as p...
...roup scientists have recently helped the Communica...re strain of cholera, which wreaked havoc in coast...athogen, transmitted through sea food, has become ...ns made the discovery. “We received calls from the...
...rological diseases seen in people who were student...y to develop. Amyotropic lateral sclerosis (ALS)//...tion. It's sometimes known as Lou Gehrig's disease...ng ALS, as well as motor neurone disease, which is...
...ording to a notice distributed by the agency, the ... United Therapeutics Corp.'s pulmonary arterial hy.... A spokesperson for the FDA told Reuters Health t...ting clearance based on an effect// on a surrogate...
...ording to new study some light was thrown on the v...ted by the condition. The study focuses on the ris.../ At least 2 percent of the population is born wit...hat eye. Some, but not all, countries place high i...
Other Medicine News:
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 W...d the pricing of its previously announced secondar... a price to the public of $22.25 per share. The s...Bain Capital Partners, DLJ Merchant Banking, J.P. ...as H. Lee Partners, L.P., certain other institutio...
(Date:11/19/2009)... , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire...q: ALXA ) announced today that its corporate pres...al Piper Jaffray Health Care Conference on Wednesd...he presentation will be webcast from The New York ...Thomas B. King, Alexza President and CEO. ,, ...
(Date:11/19/2009)... , Part of International Internet Week of...wire-USNewswire/ -- The U.S. Food and Drug Adminis...nternational effort, called the International Inte...al actions involving medical products. ,, (Logo...ALOGO ) ,, During the effort, the FDA,s Office ...
Breaking Medicine Technology:Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Biocartis Raises EUR10 Million in Series A Financing Round 5498 1Biocartis Raises EUR10 Million in Series A Financing Round 5498 2Biocartis Raises EUR10 Million in Series A Financing Round 5498 3Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 5496 1Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 5496 2Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 5496 3Clinical Force Announces that Stiris Research has Selected the Clinical Force CTMS to Manage Clinical Trials 14476 1Clinical Force Announces that Stiris Research has Selected the Clinical Force CTMS to Manage Clinical Trials 14476 2Clinical Force Announces that Stiris Research has Selected the Clinical Force CTMS to Manage Clinical Trials 14476 3
... England, April 21 Circassia Ltd, a specialty,bio...ed today that it has,initiated a phase II clinical...patients with asthma. The trial builds on positive...clinical benefits of ToleroMune allergy,therapy, a...llergy-associated,asthma. , The lastest study,...
...2905 , , DENVER, April 20 Scientists from the Ba...ay presented data at the American Association for ...epresents significant research advancements in the...e breast cancer. , , (Logo: http://www.newscom.c...nos researchers discovered that when an FDA-approv...
Other Medicine Technology:Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients 2Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference 2Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference 3
P-66
P-1066-A-SS
P-1065-SS
Mobile Instrument Stand
Medicine Products: